Clinical Translational Catalyst (CTC) Marketplace - From Discovery to Commercialisation

Date

6 Aug 2025

Time

09:00 - 13:00

Venue

Conference Hall RM 4–7, 2/F, Building 10W, 10 Science Park West Avenue, Hong Kong Science Park

Clinical Translational Catalyst (CTC) Marketplace - From Discovery to Commercialisation

On 6 August 2025, the CTC Marketplace gathered over 120 industry leaders, investors and biotech innovators to explore new pathways for clinical translation and commercialisation.

The programme featured keynotes by Prof. Tony Mok and Dr. PC Zhu, together with showcases from five HKSTP companies. Fireside chats and panels brought insights from global pharma leaders such as AstraZeneca, Lilly Gateway Labs andSimcere, alongside investors including Pivotal bioVenture Partners, SIIC and Eisai Innovation.

A dedicated business matching session connected 14 HKSTP companies with multinational corporates and investors, sparking multiple follow‑up discussions on collaboration and licensing.

Event Highlights

Entrepreneurship in Biotech – Prof Tony Mok reflected on his 29‑year journey from clinician to entrepreneur, sharing lessons on partnerships, exits and the value of rigorous legal and financial planning.

Commercialisation Strategies – Experts stressed the need for early due diligence and regulatory alignment to de‑risk biotech development.

Investment Trends –Investors and MNCs spotlighted precision medicine and novel therapeutic modalities as areas of growing momentum.

High‑Impact Networking – One‑to‑one business matching delivered meaningful connections between innovators and global industry stakeholders.

Company Directory

Clinical Translational Catalyst (CTC) Marketplace - From Discovery to Commercialisation

Share this news